DiaMedica Therapeutics Inc.DMACNASDAQ
LOADING
|||
EPS Growth Trend
Above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
5.56%
↑ 129% above average
Average (39q)
-19.40%
Historical baseline
Range
High:85.35%
Low:-418.02%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 5.56% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | -20.00% |
| Q3 2024 | -15.38% |
| Q2 2024 | 7.14% |
| Q1 2024 | 0.00% |
| Q4 2023 | -16.67% |
| Q3 2023 | 25.00% |
| Q2 2023 | 20.00% |
| Q1 2023 | -42.86% |
| Q4 2022 | -16.67% |
| Q3 2022 | 7.69% |
| Q2 2022 | 0.00% |
| Q1 2022 | 23.53% |
| Q4 2021 | 5.56% |
| Q3 2021 | -5.88% |
| Q2 2021 | 10.53% |
| Q1 2021 | 24.00% |
| Q4 2020 | -31.58% |
| Q3 2020 | -11.76% |
| Q2 2020 | 10.53% |
| Q1 2020 | 0.00% |
| Q4 2019 | 5.00% |
| Q3 2019 | 4.76% |
| Q2 2019 | 22.22% |
| Q1 2019 | -204.05% |
| Q4 2018 | -31.75% |
| Q3 2018 | 85.35% |
| Q2 2018 | -418.02% |
| Q1 2018 | 44.50% |
| Q4 2017 | -6.67% |
| Q3 2017 | 16.67% |
| Q2 2017 | 25.00% |
| Q1 2017 | -178.10% |
| Q4 2016 | 56.85% |
| Q3 2016 | -66.67% |
| Q2 2016 | -44.23% |
| Q1 2016 | 40.57% |
| Q4 2015 | -106.19% |